1. HBW Insight
  2. >>Ingredients & Safety
  3. >>Cannabis/CBD

FDA Request For Help On Hemp Regulation Gets Lower Profile In House Appropriators' Report

 
• By Malcolm Spicer

Committee’s report published with FY2025 appropriation states a different approach to establishing FDA regulation of non-drug products containing hemp as a derivative of cannabis de-scheduled as controlled substance in the US since 2018.

• Source: Shutterstock

House appropriators’ report published with their fiscal year 2025 appropriation bill for the US Food and Drug Administration could signal a shift in members’ thinking about the agency’s approach to effective regulation of the hemp products market.

Appropriators’ report published a year ago with their FY2024 appropriation for the agency stated that members recognized the FDA intended “to work with Congress on creating a regulatory framework...

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on HBW Insight for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required
Start Free Trial

Already a subscriber?

More from Cannabis/CBD

More from Ingredients & Safety